ArticleScientific reports2026
Predictors of unsuccessful tuberculosis treatment outcome in Bhutan: A retrospective study using comprehensive national tuberculosis surveillance data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extensive Endemic Transmission of Multidrug-ResistantOpen forum infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Despite the high burden of tuberculosis in Bhutan, data on treatment outcomes are limited. Using a national TB dataset from 2018 to 2021, provided by the National Tuberculosis Reference Laboratory, we conducted a retrospective cohort study to assess treatment outcomes and explore factors associated with unsuccessful TB outcomes. Of the 3,619 patients who received TB treatment, 3,330 had a recorded treatment outcome. Among these, 96.2% (n = 3,202) had a successful outcome (44.4% (n = 1,480) were cured and 51.7% (n = 1,722) completed treatment), and 3.8% (n = 128) had an unsuccessful outcome (2.8% (n = 93) died, 0.7% (n = 23) experienced treatment failure, and 0.4% (n = 12) were lost to follow-up). Multivariable logistic regression showed patients older than 60 years of age (aOR 4.3; 95% CI 2.09-10.0; p-value < 0.001), diagnosed in 2019 (aOR 1.7; 95% CI 1.03–2.86; p-value 0.041), 2021 (aOR 1.74; 95% CI 1.03–2.97; p-value 0.038), and pulmonary TB (aOR 2.69; 95% CI 1.76–4.27; p-value < 0.001) were more likely to have an unsuccessful treatment outcome. The proportion of successful TB treatment exceeded the global target rate of 90%, with a low rate of unsuccessful outcomes. Patients with pulmonary TB and elderly patients require active follow-up to ensure their treatment success increases. In-depth studies need to be conducted to understand the circumstances leading to the treatment failures and death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.